Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Tax Provisions (2022 - 2025)

Historic Tax Provisions for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $219.0 million.

  • GE HealthCare Technologies' Tax Provisions rose 12812.5% to $219.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $615.0 million, marking a year-over-year increase of 1581.92%. This contributed to the annual value of $614.0 million for FY2025, which is 1563.09% up from last year.
  • GE HealthCare Technologies' Tax Provisions amounted to $219.0 million in Q4 2025, which was up 12812.5% from $179.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' 5-year Tax Provisions high stood at $250.0 million for Q3 2023, and its period low was $96.0 million during Q4 2024.
  • Over the past 4 years, GE HealthCare Technologies' median Tax Provisions value was $147.0 million (recorded in 2022), while the average stood at $153.3 million.
  • In the last 5 years, GE HealthCare Technologies' Tax Provisions tumbled by 5025.91% in 2024 and then soared by 12812.5% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Tax Provisions stood at $151.0 million in 2022, then increased by 27.81% to $193.0 million in 2023, then crashed by 50.26% to $96.0 million in 2024, then soared by 128.12% to $219.0 million in 2025.
  • Its Tax Provisions was $219.0 million in Q4 2025, compared to $179.0 million in Q3 2025 and $113.0 million in Q2 2025.